So, some people who have a lot of money are betting that a company called Viking Therapeutics will not do well. This is important because they usually know something that others don't. The article tells us how many times these big spenders made decisions about the company and what kind of choices they made. Most of them think the company won't do well, but some still believe it will. Read from source...

- The article does not provide any clear definition or explanation of what constitutes a "whale" investor. Is it based on the amount of money invested, the number of shares owned, the trading frequency, or some other criteria? This creates confusion and ambiguity for the readers who may want to follow or learn from these large investors.
- The article uses sensationalist language such as "bearish stance", "somebody knows something is about to happen" without providing any evidence or logical reasoning to support these claims. This may appeal to emotions and curiosity of the readers, but also undermines the credibility and objectivity of the journalism.
- The article relies heavily on options history data from Benzinga, which may not be accurate, complete, or representative of the whole market. Options trading is a complex and dynamic field that requires careful analysis and interpretation of various factors, such as strike price, expiration date, volatility, liquidity, etc. The article does not demonstrate any understanding or use of these factors in its reporting.
- The article only focuses on the options trades of large investors, while ignoring other types of trading activities, such as stock purchases, sales, dividends, earnings, news, events, etc. that may also affect the performance and valuation of VKTX. This creates a biased and incomplete picture of the market situation and the company's outlook.
- The article does not provide any context or background information about Viking Therapeutics, its business model, its products, its competitors, its challenges, its opportunities, etc. This makes it hard for the readers to understand why VKTX is an interesting or relevant stock to follow or invest in.

Bearish
Reasoning: The overall sentiment of the big-money traders is split between 45% bullish and 54%, bearish. However, this implies that the majority of the large investors are expecting a decline in the stock price or at least not a significant increase. Additionally, the fact that only 1 put option was used suggests that there may be some uncertainty about the direction of the stock price, which could also indicate a bearish sentiment.

Based on the article titled "Check Out What Whales Are Doing With VKTX", I have analyzed the options trades for Viking Therapeutics (VKTX) and found the following patterns.

- The overall sentiment of the big-money traders is split between 45% bullish and 54%, bearish, which indicates a mixed outlook on the stock price direction.
- There were 11 options trades for VKTX, which is abnormal compared to the normal activity of this stock. This suggests that the traders have some insider information or a high conviction in their predictions.
- The options scanner detected 1 put option, which implies that the traders are expecting the stock price to decline and want to protect their downside risk. A put option gives them the right to sell the stock at a specified price (strike price) within a certain period of time.
- There were also 10 call options, which indicates that the traders are expecting the stock price to rise and want to benefit from the upside potential. A call option gives them the right to buy the stock at a specified price (strike price) within a certain period of time.
- The ratio of put options to call options is 1:10, which shows that the traders are more bullish than bearish on VKTX in the short term. This means that they expect the stock price to increase more than it decreases in the near future.
- The strike prices for both the put and call options range from $7.50 to $12.50, which suggests that the traders are targeting a specific price level for VKTX. This could be based on technical analysis, fundamental analysis, or some other factor that influences the stock performance.
- The expiration dates for both the put and call options range from March 18 to April 22, which means that the traders are betting on a short-term move in VKTX. This could be due to an upcoming event, news, earnings report, or regulatory decision that affects the stock.

Based on these findings, I have generated the following comprehensive investment recommendations and risks for VKTX:

1. If you are bullish on VKTX, you can buy call options with a strike price between $7.50 and $12.50 and an expiration date between March 18 and April 22. This will allow you to benefit from the upside potential of the stock if it rises above the strike price before the expiration date. However, you will also incur a premium cost for the options, which will reduce your profits